Physician profile
Jay Karri
NPI 1912430505
$13,810.61
in general payments reported to CMS, 2019-2025
11 companies · $671 in 2025
The $671 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11K · 2022: $430 · 2023: $628 · 2024: $1,392 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,680 · Travel and Lodging: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,679.77 |
| Travel and Lodging | $1,011.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,349.93 | 2021-2025 | Inceptiv |
| Boston Scientific Corporation | $2,030.02 | 2021-2025 | General - Pain Management |
| Spr Therapeutics, INC | $675.75 | 2022-2025 | Sprint Pns System |
| Stratus Medical, LLC | $287.38 | 2023-2025 | Nimbus |
| International Rehabilitative Sciences, INC | $147.33 | 2024-2025 | Rs 4i Plus Sequential Stimulator |
| Nevro Corp. | $108.65 | 2023 | Senza |
| Biotronik Nro, INC. | $78.38 | 2025 | Prospera |
| Stryker Corporation | $51.63 | 2025 | Optablate |
| Abbott Laboratories | $41.98 | 2023 | Proclaim |
| Ethicon US, LLC | $21.48 | 2025 | Dermabond Prineo, Stratafix, Ethicon |
| Averitas Pharma INC. | $18.08 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Karri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.